Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 74851-74900 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05818384
Wakaya: Rising Up for Choctaw Youth Health
NARecruiting
176 participants
Started: Apr 28, 2023 · Completed: Apr 30, 2027
4 conditions2 sponsors2 locations
NCT05841563
Clinical Trial of PM54 in Advanced Solid Tumors Patients.
PHASE1Recruiting
125 participants
Started: Apr 28, 2023 · Completed: Apr 30, 2027
1 condition1 sponsor3 locations
NCT05797558
Unilateral Primary Aldosteronism, Mineralocorticoid Antagonists Versus Surgical Treatment
NARecruiting
80 participants
Started: Apr 28, 2023 · Completed: May 28, 2028
1 condition3 sponsors3 locations
NCT07039227
Evaluation of the Prognostic Value of Immature Platelet Fraction
N/AActive, not recruiting
200 participants
Started: Apr 28, 2023 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT05789485
A Study on the Effects of Exercise on Side Effects From Treatment for Gastrointestinal Cancers
PHASE2Recruiting
216 participants
Started: Apr 28, 2023 · Completed: Apr 18, 2027
1 condition1 sponsor8 locations
NCT06365983
Comparison of Free Gingival Graft and Linear Incision for Connective Tissue
NARecruiting
24 participants
Started: Apr 28, 2023 · Completed: Apr 28, 2026
4 conditions1 sponsor1 location
NCT05456841
Empathic Communication Skills (ECS) Training
NARecruiting
1,232 participants
Started: Apr 28, 2023 · Completed: Aug 31, 2026
1 condition3 sponsors10 locations
NCT05793996
The Prevalence of Iron Deficiency and the Effectiveness of Ferinject® in Patients With HFpEF (ID-HFpEF)
PHASE4Recruiting
100 participants
Started: Apr 28, 2023 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT06508242
Effects Of Vitamin D On Bone, Muscle, And Adipose Tissue In Obese Subjects
PHASE4Recruiting
80 participants
Started: Apr 28, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT05880043
GIC-102, Intravenous Allogeneic NK Cells, in Subjects With Advanced Solid Cancers and R/R Hematologic Malignancies
PHASE1/PHASE2Recruiting
50 participants
Started: Apr 28, 2023 · Completed: Jun 30, 2026
3 conditions1 sponsor4 locations
NCT05736731
A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants With Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression
PHASE1/PHASE2Active, not recruiting
160 participants
Started: Apr 28, 2023 · Completed: Dec 31, 2026
16 conditions2 sponsors8 locations
NCT05794477
A Study of SHR-1802 in Combination With Adebrelimab in Patients With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
132 participants
Started: Apr 28, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05822739
Safety and Efficacy Study of Parkinson's Disease Gene Therapy Drug (BBM-P002)
EARLY_PHASE1Not yet recruiting
6 participants
Started: Apr 28, 2023 · Completed: Dec 30, 2028
1 condition1 sponsor1 location
NCT05701527
A Study of EBC-129 in Advanced Solid Tumours
PHASE1Recruiting
95 participants
Started: Apr 28, 2023 · Completed: Dec 24, 2026
1 condition2 sponsors5 locations
NCT05799651
Safety and Immunogenicity of Glycovax-002 Vaccine in Healthy Adults
PHASE1Active, not recruiting
36 participants
Started: Apr 28, 2023 · Completed: Dec 31, 2024
1 condition5 sponsors1 location
NCT06100081
Real-time Targeted Fluorescence Endoscopy for Detection of the Primary Cancer Lesion in Patients With a Metastasis of Unknown Primary Tumor in the Head and Neck
NARecruiting
35 participants
Started: Apr 28, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06281691
GreenBladder - Early Detection of Bladder Cancer in Residents in Greenland Using a Urinary Marker and a Mobile Cystoscopy Unit
N/AEnrolling by invitation
150 participants
Started: Apr 28, 2023 · Completed: Nov 30, 2025
1 condition5 sponsors2 locations
NCT05938725
KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis
PHASE1/PHASE2Recruiting
32 participants
Started: Apr 28, 2023 · Completed: Aug 31, 2026
3 conditions1 sponsor6 locations
NCT05537935
Low Dose Naltrexone for Pain in Patients With HIV
PHASE4Recruiting
60 participants
Started: Apr 28, 2023 · Completed: Dec 31, 2026
2 conditions1 sponsor3 locations
NCT05841030
A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)
N/AActive, not recruiting
545 participants
Started: Apr 28, 2023 · Completed: Nov 21, 2025
1 condition1 sponsor94 locations
NCT05857774
Respiratory Muscle Structure and Function in Mechanically Ventilated Patients and Long-term Outcomes
N/ARecruiting
230 participants
Started: Apr 27, 2023 · Completed: Jun 30, 2026
5 conditions1 sponsor1 location
NCT05779943
Comparison of 18F-rhPSMA-7.3 PET/CT With and Without Furosemide in Biochemical Recurrence of Prostate Cancer
PHASE2Active, not recruiting
20 participants
Started: Apr 27, 2023 · Completed: Jul 1, 2028
2 conditions3 sponsors4 locations
NCT05561088
Efficacy and Safety of Head Acupuncture After Mechanical Thrombectomy for Acute Ischemic Stroke
NARecruiting
272 participants
Started: Apr 27, 2023 · Completed: Oct 31, 2028
3 conditions1 sponsor1 location
NCT05331170
Viral Mucosal Reprogramming
PHASE2Recruiting
75 participants
Started: Apr 27, 2023 · Completed: May 1, 2027
4 conditions2 sponsors1 location
NCT05804045
Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER)
PHASE3Active, not recruiting
90 participants
Started: Apr 27, 2023 · Completed: Jun 30, 2028
3 conditions1 sponsor40 locations
NCT05870124
Clinical Study of a Micro-Implantable Pulse Generator for the Treatment of Peripheral Neuropathic Pain (COMFORT 2)
NAActive, not recruiting
185 participants
Started: Apr 27, 2023 · Completed: Dec 31, 2027
3 conditions1 sponsor2 locations
NCT06081205
Study of Patients Admitted to a Cardiac Intensive Care Unit With Acute CardioVascular Disease
N/ARecruiting
1,000 participants
Started: Apr 27, 2023 · Completed: Apr 26, 2027
4 conditions1 sponsor1 location
NCT05956340
A Study of Spoken Language in Mania
NARecruiting
20 participants
Started: Apr 27, 2023 · Completed: Jan 31, 2026
2 conditions1 sponsor1 location
NCT05976672
Machine Learning Technology in Predicting Relapse and Implementing Peer Recovery Intervention Before Drug Use Occurs
NAActive, not recruiting
500 participants
Started: Apr 27, 2023 · Completed: Apr 26, 2028
1 condition1 sponsor1 location
NCT05894083
A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze)
PHASE2Recruiting
150 participants
Started: Apr 27, 2023 · Completed: Dec 31, 2029
2 conditions1 sponsor1 location
NCT05788601
Dapiglutide for the Treatment of Obesity
PHASE2Active, not recruiting
54 participants
Started: Apr 27, 2023 · Completed: Aug 15, 2025
2 conditions2 sponsors1 location
NCT05970523
The Effects of Core Stabilization Exercises on Balance, Trunk Muscle Endurance and Posture on Sedentary Individuals
NAActive, not recruiting
50 participants
Started: Apr 27, 2023 · Completed: May 31, 2024
2 conditions1 sponsor1 location
NCT05707975
Eco-anxiety and Suicide
N/ARecruiting
261 participants
Started: Apr 27, 2023 · Completed: Nov 27, 2026
4 conditions1 sponsor1 location
NCT06405685
Nimotuzumab Plus AG in Pancreatic Cancer With Liver Metastasis
PHASE2Recruiting
30 participants
Started: Apr 27, 2023 · Completed: Oct 30, 2025
1 condition1 sponsor1 location
NCT05671861
Evaluating a Low-Cost Therapeutic Device in Managing Head and Neck Cancer Patients With Radiation-Related Trismus
NARecruiting
125 participants
Started: Apr 27, 2023 · Completed: Mar 31, 2028
2 conditions2 sponsors1 location
NCT05405387
Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant
PHASE2Recruiting
120 participants
Started: Apr 27, 2023 · Completed: Sep 30, 2027
1 condition1 sponsor1 location
NCT05587894
OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients: a Randomized Factorial Controlled Strategy Trial
PHASE2Recruiting
256 participants
Started: Apr 27, 2023 · Completed: May 31, 2025
2 conditions2 sponsors18 locations
NCT06729944
Diagnostic Value of Next-Generation Sequencing Analysis in Biliary Tract Tumours
NARecruiting
50 participants
Started: Apr 27, 2023 · Completed: Jun 30, 2026
3 conditions1 sponsor1 location
NCT06320028
Altering Default Mode Network Activity With Transcranial Focused Ultrasound to Reduce Depressive Symptoms
PHASE1/PHASE2Active, not recruiting
20 participants
Started: Apr 27, 2023 · Completed: Jun 3, 2024
2 conditions2 sponsors1 location
NCT05990166
Assessing the Effect of a Mineral-enriched Powder on Iron Deficiency in Women of Reproductive Age
PHASE2Active, not recruiting
150 participants
Started: Apr 27, 2023 · Completed: May 30, 2026
2 conditions4 sponsors1 location
NCT04919629
APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion
PHASE2Recruiting
60 participants
Started: Apr 27, 2023 · Completed: Apr 30, 2027
15 conditions2 sponsors1 location
NCT05942222
A Real-world, Head-to-head Comparison of Dupilumab Versus Mepolizumab in Danish Patients With Chronic Rhinosinusitis With Nasal Polyps
PHASE4Active, not recruiting
220 participants
Started: Apr 27, 2023 · Completed: May 1, 2026
3 conditions1 sponsor9 locations
NCT05756751
IMPACT EU Post-Market Clinical Follow-Up Study
NAActive, not recruiting
123 participants
Started: Apr 27, 2023 · Completed: Aug 8, 2026
1 condition1 sponsor13 locations
NCT05835687
Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors
PHASE1Recruiting
48 participants
Started: Apr 27, 2023 · Completed: Mar 31, 2028
7 conditions1 sponsor1 location
NCT05943067
CD45RA Depleted DLI After TCRα/β Depleted Haploidentical HCT
PHASE1/PHASE2Recruiting
60 participants
Started: Apr 27, 2023 · Completed: Dec 31, 2028
1 condition1 sponsor2 locations
NCT05799248
Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management
PHASE3Recruiting
113 participants
Started: Apr 27, 2023 · Completed: May 28, 2024
1 condition2 sponsors1 location
NCT05805319
Dietary Intervention for NSCLC Patients Treated With ICI
NARecruiting
80 participants
Started: Apr 27, 2023 · Completed: Mar 30, 2026
1 condition1 sponsor1 location
NCT05558475
The DigIT Trial: The Effectiveness and Implementation of a Coached Digital Insomnia Treatment Program in a Regional Healthcare System.
NAActive, not recruiting
244 participants
Started: Apr 27, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor5 locations
NCT06370065
Serplulimab Combined With Bevacizumab Biosimilar and HAIC in Advanced Hepatocellular Carcinoma (HCC) Patients
PHASE2Recruiting
35 participants
Started: Apr 27, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05716451
Pilot Study on Device-assisted Mobilisation of Critically Ill Patients
NAActive, not recruiting
40 participants
Started: Apr 27, 2023 · Completed: Sep 2, 2025
2 conditions1 sponsor1 location